AccuPulse PFA System Achieves Successful Clinical Debut in China: First-in-Nation Procedure Completed at Shenzhen Bao'an People's Hospital

Recently,Shenzhen Bao'an People's HospitalAs one of the first clinical application units in China, byDirector Fang Xianhongand the teamApplication of AccuPulse by AccuPulse Medical^®Single-use Cardiac Pulsed Field Ablation Catheter and AccuBlator^®The cardiac pulsed field ablation system successfully performed a pulsed field ablation (PFA) procedure on a patient with atrial fibrillation.

Schematic Diagram Before and After Pulmonary Vein Isolation

Director Fang gave a positive evaluation of the AccuPulse Cardiac Pulse Ablation System used in this surgical procedure. He fully affirmed the system's effectiveness and reliability in paroxysmal atrial fibrillation ablation surgeries. Director Fang noted that the overall operation of the system is convenient, with an efficient PFA ablation process, completing all pulmonary vein isolations within 29 minutes. Particularly commendable is the excellent performance of the catheter control, which fully meets the various requirements of paroxysmal atrial fibrillation surgery. He looks forward to the system accumulating more successful experiences in future clinical applications.

Flexible Adaptation, Precise Contact:Its unique 7.5F adjustable loop diameter design can flexibly match the pulmonary vein anatomy of different patients, achieving personalized adaptation and significantly improving the adaptability and safety of the operation.

Intelligent docking, real-time feedback:The system is equipped with AccuPulse's independently developed impedance contact prompting technology, which can monitor the catheter-tissue contact quality in real time, clearly indicate the contact status, assist operators in achieving stable and reliable catheter manipulation, and provide a solid guarantee for precise ablation.

Efficient Integration, Streamlined Processes:The circular catheter integrates mapping, modeling, and ablation functions, rapidly constructing a three-dimensional electroanatomical model of the heart during surgery, accurately locating lesions, and significantly reducing reliance on additional high-density mapping catheters in traditional procedures. This not only decreases surgical complexity but also saves on consumable costs, providing atrial fibrillation patients with a safer, more effective, and less invasive treatment option.

AccuPulse's newly approved single-use cardiac pulsed field ablation catheter has overcome the challenges of stability and anatomical adaptability in PFA ablation catheters, providing a precise and reliable solution for pulmonary vein isolation (PVI).^®The unique 7.5F adjustable loop diameter design of the cardiac pulsed field ablation catheter allows for flexible adaptation to pulmonary vein ablation in different anatomical structures. Intelligent contact indication and flexible electrode selection give operators complete control, enabling precise pulsed field ablation!

Safer:7.5F Ultra-Fine Catheter, Reducing Tissue Damage

More Stable:Smart Snap Tips for More Precise Operation

AccuPulse Medical Technology Co., Ltd. is an innovative company based in Suzhou that focuses on the research, development, and industrialization of cutting-edge technologies in the field of cardiac electrophysiology. The company’s core team possesses deep expertise in electrophysiological technology and extensive experience in the industrialization of medical devices, consistently striving to provide safer, more efficient, and more convenient treatment options for patients with arrhythmias such as atrial fibrillation.

This time, AccuPulse^®Disposable Cardiac Pulse Electric Field Ablation Catheter and AccuBlator^®The successful application of the cardiac pulsed electric field ablation system at the People's Hospital of Bao'an District, Shenzhen, marks a milestone achievement for AccuPulse in the field of innovative electrophysiological treatment technology.

Director Physician at Guangdong Provincial People's Hospital, Vice President of Bao'an District People's Hospital (Shenzhen Hospital of Guangdong Provincial People's Hospital), Doctor of Medicine, Director of Cardiology Department II. Senior member of the American Heart Rhythm Society (FHRS), Deputy Director of the Arrhythmia Intervention Quality Control Center of Guangdong Provincial Health Commission. Specializes in cardiac pacing, diagnosis of arrhythmias, radiofrequency ablation for premature ventricular contractions, ventricular tachycardia, and various supraventricular tachycardias, as well as ablation and cryoablation for atrial fibrillation, left atrial appendage closure, and leadless pacemaker technology. Graduated from Tongji Medical College of Huazhong University of Science and Technology in 1992, and was a visiting scholar at the University of Alabama School of Medicine. Serves as a committee member of the Cardiac Electrophysiology Group of the Chinese Society of Cardiac Pacing and Electrophysiology under the Chinese Medical Association, Deputy Chairman of the Cardiovascular Disease Quality Control Management Branch of the Guangdong Provincial Hospital Association, Fifth Committee Member of the Guangdong Provincial Medical Association’s Cardiac Pacing and Electrophysiology Branch, mentor at the National Health and Family Planning Commission’s Arrhythmia Training Base, Deputy Chairman of the Guangdong Provincial Biomedical Engineering Society’s Arrhythmia Branch, committee member of the Innovation and Transformation Group of the Chinese Medical Association, Standing Committee Member of the Left Atrial Appendage Occlusion Working Group of the Chinese Society of Cardiac Pacing and Electrophysiology, and Editorial Board Member of the Ninth Editorial Committee of the "Chinese Journal of Interventional Cardiology."